CurrentOscar HealthPolicy N/A

Urine Culture Testing for Bacteria

Customize your policy alerts

Sign up for all Oscar Health policy alerts

Know when Oscar Health releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Coverage and medical-necessity criteria for urine culture testing, including isolate identification and antibiotic susceptibilities when applicable, for individuals with suspected urinary tract infection or bacteriuria.

Policy Summary

PayerOscar Health

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy N/A

Change TypeBackground, guideline, recommendation, and reference updates

Effective DateJan 1, 202757d

Last ReviewSep 28, 2026

Next Review DateN/A

Key ActionDocument the clinical features supporting urine culture, including symptoms, pregnancy, recurrent or complicated UTI risk factors, or pediatric risk indicators.

SourceLink

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentOscar HealthPolicy N/A

Urine Culture Testing for Bacteria

Customize your policy alerts

Sign up for all Oscar Health policy alerts

Know when Oscar Health releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerOscar Health

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy N/A

Change TypeBackground, guideline, recommendation, and reference updates

Effective DateJan 1, 202757d

Last ReviewSep 28, 2026

Next Review DateN/A

Key ActionDocument the clinical features supporting urine culture, including symptoms, pregnancy, recurrent or complicated UTI risk factors, or pediatric risk indicators.

SourceLink

POLICY UPDATE CHANGES

The policy was updated to revise its background, guidelines and recommendations, and evidence-based scientific references.

4Covered clinical situations

3Situations not meeting criteria

8Applicable procedure codes

41Scientific references

Medical Necessity and Guideline Criteria

Covered indications

Urine culture testing, including isolate identification and antibiotic susceptibilities when applicable, meets criteria when ANY of the following applies:

Qualifying clinical indication

Pregnancy with UTI: The individual is pregnant and has a urinary tract infection.
Qualifying urological intervention: The individual is asymptomatic and is undergoing a urological intervention that breaches the mucosa; testing is performed before the procedure.Before the procedure
Possible UTI or bacteriuria: The individual exhibits at least one sign or symptom of a possible UTI or bacteriuria.At least 1 sign or symptom
Symptoms may be age- or population-specific, including urinary symptoms, fever, chills, flank or back pain, nausea or vomiting, worsening incontinence, or delirium.
Assessment of pyelonephritis: Testing is performed to assess pyelonephritis.

Not medically necessary or not meeting criteria

Urine culture testing does not meet criteria when ANY of the following applies:

Nonqualifying situation

Other asymptomatic UTI or bacteriuria: The individual has an asymptomatic UTI or asymptomatic bacteriuria that is not covered by the qualifying pre-procedure indication.
Clinical resolution of uncomplicated UTI: The individual shows evidence of clinical resolution of infection and follow-up culture is being performed for an uncomplicated UTI.
Initial screening for asymptomatic prostatitis: Testing is performed as part of initial screening for asymptomatic prostatitis.
Prostate biopsy assessment or prognosis: Testing is performed as part of assessment or prognosis of a prostate biopsy.

Guideline-supported indications for urine culture

Guideline-supported situations in which urine culture or related microbiologic testing is recommended include ANY of the following:

Guideline-supported indication

Upper, systemic, complicated, or recurrent infection: Suspected acute pyelonephritis or systemic UTI, complicated UTI, urosepsis, recurrent symptomatic UTI, or symptoms that persist or recur within four weeks after treatment.
For urosepsis, obtain urine and two sets of blood cultures before antimicrobial treatment.
Atypical or specialized presentation: Atypical cystitis symptoms, bacterial prostatitis managed as complicated UTI, suspected acute infective epididymitis, or urethritis requiring pathogen-directed testing.
Pregnancy or urologic intervention: Pregnancy with suspected or screened asymptomatic bacteriuria, or planned urologic instrumentation or procedure that breaches the mucosa or causes mucosal trauma.
Midstream urine culture is the recommended method for diagnosing asymptomatic bacteriuria in pregnancy.

Situations where routine culture or ASB screening is discouraged

Routine screening or culture is discouraged when ANY of the following applies:

Discouraged screening or treatment

Asymptomatic population without accepted indication: The individual is asymptomatic and belongs to a population for which routine screening or treatment of asymptomatic bacteriuria is discouraged, including healthy nonpregnant adults, children, older adults, patients with diabetes, most transplant recipients beyond the specified early post-transplant period, nonrenal solid-organ transplant recipients, patients with spinal cord injury, or short-term catheterized patients.
Exceptions include pregnancy and urologic procedures involving mucosal trauma.
Routine catheter testing or invalid indicators: Routine culture is being performed in an asymptomatic catheterized patient, or pyuria, cloudy urine, or odorous urine is being used alone to diagnose catheter-associated UTI.
Routine follow-up culture: Follow-up culture is being performed after an uncomplicated UTI when clinical resolution has occurred.

Pediatric urine culture collection and sequencing

For a febrile infant or young child, collection and testing should follow the applicable pathway:

Pediatric testing pathway

Immediate antimicrobial therapy required: A febrile infant requires antimicrobial therapy because of ill appearance or another pressing reason.
Obtain urine for culture and urinalysis before antimicrobial administration, using catheterization or suprapubic aspiration; urine-bag culture is not reliable for establishing UTI.
No immediate antimicrobial therapy required and not low risk
- Collection option: Obtain catheterized or suprapubic-aspirate urine for culture and urinalysis, or obtain urine by a convenient method for urinalysis and proceed to catheterized or suprapubic-aspirate culture if urinalysis suggests UTI.Positive leukocyte esterase, nitrite, leukocytes, or bacteria on urinalysis
  If fresh urine has negative leukocyte esterase and nitrite results, clinical monitoring without antimicrobial therapy may be reasonable, although UTI is not excluded with certainty.

Asymptomatic kidney transplant recipients

Routine urine culture collection or treatment of bacteriuria is discouraged when all of the following apply:

Asymptomatic kidney transplant recipient beyond two months: The individual is an asymptomatic kidney transplant recipient more than two months after kidney transplantation.>2 months after kidney transplantation

Routine culture collection or treatment of bacteriuria is not recommended. If screening has occurred and asymptomatic bacteriuria is found, the guidance recommends a second culture before deciding whether to treat.

Asymptomatic adults

Routine urine culture collection is discouraged when all of the following apply:

Asymptomatic adult without an exception: The adult lacks symptoms localizing to the urinary tract and lacks fever, and is not pregnant or undergoing genitourinary instrumentation where mucosal bleeding is expected.No urinary tract symptoms or fever

For an asymptomatic individual, urine culture testing meets criteria only when performed before a urological intervention that breaches the mucosa. Isolate identification and antibiotic susceptibility testing are included when applicable.

Follow-up urine culture testing does not meet criteria for an uncomplicated UTI when there is evidence of clinical resolution. Clinical resolution is considered adequate for assessing treatment effectiveness in this setting.

Urine culture testing does not meet criteria when used for initial screening for asymptomatic prostatitis or for assessment or prognosis of a prostate biopsy. The policy states that available published literature does not confirm that testing is required and beneficial for these purposes.

Routine screening or treatment of asymptomatic bacteriuria does not meet criteria for most nonpregnant, asymptomatic populations, including healthy adults, children, older adults, individuals with diabetes, most transplant recipients, individuals with spinal cord injury, and certain catheterized patients. Accepted exceptions include pregnancy and urologic procedures involving mucosal trauma.

Routine follow-up culture after clinical resolution of an uncomplicated UTI does not meet criteria. Routine culture of an asymptomatic catheterized patient is also discouraged, and urine culture is not indicated when suspected torsion is the cause of acute scrotal pain or swelling.

Routine urine culture in adults without urinary tract-localizing symptoms or fever does not meet criteria. Exceptions apply when the individual is pregnant or is undergoing genitourinary instrumentation in which mucosal bleeding is expected.

Routine urine culture collection or treatment of bacteriuria does not meet criteria for an asymptomatic kidney transplant recipient more than 2 months after transplantation. The cited guidance recommends against routine screening and treatment in this population.

Additional testing for asymptomatic UTI or asymptomatic bacteriuria does not meet criteria when there is no accepted indication. This includes surveillance cultures, routine testing after clinical resolution, and follow-up testing performed solely because bacteriuria was previously identified. Pregnancy and qualifying genitourinary instrumentation remain recognized exceptions.

Urine culture is low-value and potentially harmful when obtained from an asymptomatic adult without pregnancy or qualifying genitourinary instrumentation. Unnecessary positive findings may prompt avoidable antibiotic treatment, adverse drug events, resistant organisms, or additional evaluation.

Pyuria, cloudy urine, odorous urine, or dipstick findings alone are insufficient substitutes for clinical assessment. In catheterized patients, these findings should not be used alone to diagnose catheter-associated UTI or to distinguish infection from asymptomatic bacteriuria.

Qualifying Clinical Presentations

Pregnant individual with a urinary tract infection

Urine culture testing, with isolate identification and antibiotic susceptibilities when applicable, meets criteria when both of the following apply:

Pregnancy with UTI: The individual is pregnant and has a urinary tract infection.

Midstream urine culture is the recommended method for diagnosing asymptomatic bacteriuria in pregnancy.

Asymptomatic individual undergoing a urological intervention that breaches the mucosa

Urine culture testing meets criteria when all of the following apply:

Qualifying pre-procedure testing: The individual is asymptomatic and is undergoing a urological intervention or endoscopic urologic procedure that breaches the mucosa or causes mucosal trauma.Before the procedure

Testing includes isolate identification and antibiotic susceptibilities when applicable.

Repeat and Follow-Up Testing

Urine culture frequency limits

Follow-up cultureAvoid follow-up urine culture after treatment of an uncomplicated UTI when clinical resolution has occurred.

Asymptomatic catheterized patientsAvoid routine urine cultures in asymptomatic catheterized patients; pyuria, cloudy urine, or odorous urine alone should not establish CAUTI.

Kidney transplant recipientsAvoid routine culture or treatment of bacteriuria in asymptomatic kidney transplant patients more than two months after transplantation, except as addressed by applicable guidance.

Pediatric urine culture frequency limit

TriggerSend a urine culture when a child's infection does not respond to treatment within 24–48 hours.

Prior sampleApply this additional culture step if no urine sample has already been sent.

Applicable Procedure Codes

Applicable CPT/HCPCS Procedure CodesCPT

87077	Culture, bacterial; aerobic isolate, additional methods required for definitive identification, each isolate.
87086	Culture, bacterial; quantitative colony count, urine.
87088	Culture, bacterial; with isolation and presumptive identification of each isolate, urine.
87140	Culture, typing; immunofluorescent method, each antiserum.
87147	Culture, typing; immunologic method, other than immunofluorescence (eg, agglutination grouping), per antiserum.
87149	Culture, typing; identification by nucleic acid (DNA or RNA) probe, direct probe technique, per culture or isolate, each organism probed.
87181	Susceptibility studies, antimicrobial agent; agar dilution method, per agent (eg, antibiotic gradient strip).
87186	Susceptibility studies, antimicrobial agent; microdilution or agar dilution (minimum inhibitory concentration [MIC] or breakpoint), each multi-antimicrobial, per plate.

Documentation, Ordering, and Denial Risks

Documentation Required

Accurate Service Documentation

Submit accurate documentation of the services performed and code claims according to applicable industry-standard coding and billing guidelines. Coverage does not guarantee reimbursement; authorization, medical necessity, benefit coverage, and the member’s state of residence may also affect payment.

Use applicable Uniform Billing Editor, AMA/CPT, CPT Assistant, HCPCS, ICD-10-CM/PCS, NDC, DRG, CMS National Correct Coding Initiative, CCI edits, and other CMS guidance.
Document the clinical indication, relevant symptoms or presentation, test performed, and other information supporting medical necessity.

Documentation Required

Clinical Indication and Risk Factors

Document the symptoms, clinical presentation, and risk factors supporting urine culture testing, including suspected UTI or bacteriuria, pyelonephritis, complicated UTI, pregnancy, or an upcoming urological procedure that breaches the mucosa.

Capture urinary symptoms or other signs of possible infection and atypical or persistent symptoms when present.

Clinical Background

Urinary tract infections may be symptomatic or asymptomatic and may be uncomplicated or complicated. Complicated infections include those in men, pregnant individuals, patients with urinary tract abnormalities, indwelling catheters, renal disease, or immunocompromising conditions. Bacteriuria or pyuria alone does not establish symptomatic infection, and inappropriate testing or treatment of asymptomatic bacteriuria may contribute to adverse effects and antimicrobial resistance.

Clinical Terms

Definition

DefinitionBacteriuria is the presence of bacteria in the urine.

Possible presentationBacteriuria may occur in symptomatic or asymptomatic urinary tract infections.

Related findingPyuria is the presence of pus in the urine and may occur with bacteriuria, but these findings alone do not establish symptomatic infection.

Definition

DefinitionCystitis is an infection of the bladder or lower urinary tract.

Clinical categoryCystitis is a type of urinary tract infection.

Presentation

Who May Order and When

Note

Order when clinical criteria are met

The treating clinician should order the urine culture when clinical criteria are met; the policy does not restrict ordering to a particular clinician specialty. For pediatric patients, the specimen may require catheterization or suprapubic aspiration, and urine should be collected before antibiotics when feasible.

Excluded Testing Situations

Urine culture testing for asymptomatic UTI or asymptomatic bacteriuria is not covered unless performed before a qualifying urological intervention that breaches the mucosa. Pregnancy is an accepted clinical exception to routine asymptomatic bacteriuria screening restrictions.

Follow-up urine culture is not covered for an uncomplicated UTI after the individual has demonstrated clinical resolution. Routine surveillance after successful treatment is not supported when symptoms have resolved.

Routine screening or surveillance urine culture without an accepted clinical indication is not covered, particularly in nonpregnant asymptomatic individuals. The guidance discourages screening or treatment because surveillance may produce false-positive or false-negative results and lead to unnecessary antibiotic exposure.

Additional nonqualifying urine culture testing is not covered, including routine cultures in asymptomatic catheterized patients, culture based only on nonspecific urine findings, and culture when suspected testicular torsion is the cause of acute scrotal pain or swelling.

Surveillance or screening cultures for asymptomatic bacteriuria in nonpregnant individuals are not covered without an accepted indication. This includes routine screening in healthy adults, children, older adults, individuals with diabetes, and other populations for whom guidelines recommend against screening or treatment.

Routine urine culture in an asymptomatic catheterized patient is not covered. Catheter status alone, without compatible clinical findings, is not an indication for culture.

Policy Summary

PayerOscar Health

PolicyUrine Culture Testing for Bacteria

Policy CodePolicy N/A

Change TypeBackground, guideline, recommendation, and reference updates

Effective DateJan 1, 202757d

Last ReviewSep 28, 2026

Next Review DateN/A

Key ActionDocument the clinical features supporting urine culture, including symptoms, pregnancy, recurrent or complicated UTI risk factors, or pediatric risk indicators.

SourceLink

On This Page

Pediatric indication: A febrile child has risk factors or findings supporting UTI, including age under 3 months, suspected upper UTI, high or intermediate risk of serious illness, positive leukocyte esterase or nitrite, recurrent UTI, failure to respond within 24–48 hours, or symptoms inconsistent with dipstick findings.

Nonpregnant adult without symptoms or fever: A culture is being collected from an adult without urinary tract-localizing symptoms or fever, and no accepted exception applies.

The cited exceptions are pregnancy and genitourinary instrumentation where mucosal bleeding is expected.

Individual exhibiting at least one sign or symptom of possible UTI or bacteriuria

Urine culture testing meets criteria when at least one sign or symptom of possible UTI or bacteriuria is present:

At least 1 sign or symptom

Bladder or lower-tract symptoms: Pain or burning with urination, frequent urination, persistent urge to urinate, bloody urine, or pressure or cramping in the groin or lower abdomen.
Kidney-infection symptoms: Fever, chills, lower back or flank pain, nausea, or vomiting.
Infant, baby, or toddler presentation: Fever, abdominal pain or fullness, strong or foul-smelling urine, weight loss, irritability, vomiting, poor feeding, fatigue, jaundice, or diarrhea.
Older-child presentation: New daytime accidents or bedwetting after toilet training, painful or difficult urination, lower abdominal, back, or side discomfort, malodorous, cloudy, or bloody urine, nausea or vomiting, fever or chills, fatigue, or frequent urgent small-volume urination.
Older, frail, or catheterized individual: Worsening incontinence, new shivering or rigors, or a change in behavior such as agitation or delirium.

Assessment of pyelonephritis

Urine culture testing, including isolate identification and antibiotic susceptibilities when applicable, meets criteria for assessment of pyelonephritis:

Suspected or assessed pyelonephritis: The testing is performed to assess suspected or established pyelonephritis.

Guidance supports urine culture and antimicrobial susceptibility testing in patients with pyelonephritis.

Urine culture for pyelonephritis, systemic or complicated UTI, urosepsis, recurrent or atypical symptoms, pediatric fever, pregnancy, and qualifying procedures

Urine culture is supported when ANY of the following clinical situations applies:

Guideline-supported culture indication

Upper, systemic, or complicated infection: Suspected pyelonephritis, systemic UTI, complicated UTI, or urosepsis.
For urosepsis, obtain urine and two sets of blood cultures before antimicrobial treatment.
Recurrent or persistent infection: Recurrent symptomatic UTI, or symptoms that persist or recur within four weeks after treatment.
Atypical symptoms: The individual presents with atypical cystitis symptoms or clinical symptoms and signs that do not correlate with dipstick findings.
Pediatric febrile presentation: The child is under 3 months, has suspected upper UTI, has high or intermediate risk of serious illness, has positive leukocyte esterase or nitrite, has recurrent UTI, fails to respond within 24–48 hours when no sample has already been sent, or requires immediate treatment for another serious indication.
Pregnancy-related ASB evaluation: The individual is pregnant and is being evaluated for suspected or asymptomatic bacteriuria.
Qualifying urologic procedure: The individual is undergoing planned urologic instrumentation or a procedure that breaches the mucosa or causes mucosal trauma.
Obtain the culture before antimicrobial therapy when feasible.

Targeted microbiologic testing for urethritis, bacterial prostatitis, and suspected infective epididymitis

Use targeted microbiologic testing according to the clinical presentation:

Targeted testing indication

Urethritis: The individual meets clinical criteria for urethritis.
Testing may include Gram stain or urethral smear, first-void urine or urethral smear NAAT for chlamydial and gonococcal infection, and urethral swab culture before treatment when NAAT is positive for gonorrhea to assess antimicrobial resistance.
Bacterial prostatitis: The individual has suspected or diagnosed bacterial prostatitis.
Use laboratory urine culture as for complicated UTI in acute bacterial prostatitis; for chronic bacterial prostatitis, perform a Meares and Stamey two- or four-glass test. Do not use initial screening for asymptomatic prostatitis as an indication.
Suspected acute infective epididymitis: The individual has suspected acute infective epididymitis rather than suspected testicular torsion.
Obtain midstream and first-void urine for pathogen identification by culture and NAAT. Suspected torsion requires urgent surgical evaluation rather than urine culture.

Pediatric contextNICE includes failure to respond within 24–48 hours among indications for urine culture in babies and children.

For complicated UTI, document relevant factors such as diabetes, immunosuppression, urinary tract abnormalities, vesicoureteral reflux, recent instrumentation, male sex, pregnancy, or healthcare-associated infection.

For pyelonephritis or systemic UTI, document the clinical assessment supporting culture and susceptibility testing.

Documentation Required

Pediatric Specimen and Treatment Context

For febrile infants and children, document age, fever and illness severity, clinical risk assessment, urinalysis findings, specimen collection method, and whether antibiotics are required before culture collection. Obtain an appropriate specimen before antimicrobial therapy whenever possible.

For children 2–36 months with fever greater than 39°C and no other source, obtain urinalysis; unless completely normal, obtain culture by catheterization or suprapubic aspirate. A toilet-trained child may provide a midstream specimen.
For a febrile infant requiring immediate antimicrobial therapy because of ill appearance or another pressing reason, obtain urine for culture and urinalysis before treatment using catheterization or suprapubic aspirate; bag cultures are not reliable for establishing UTI.
If the child is not low risk and immediate antibiotics are not required, document the urinalysis-based pathway. A positive leukocyte esterase, nitrite, or microscopic finding should be followed by catheterized or suprapubic-aspirate culture.
Document collection before antibiotics because a single effective dose can rapidly sterilize urine. Also document indications such as age under 3 months, suspected pyelonephritis, serious illness risk, recurrent UTI, treatment failure, or discordance between symptoms and dipstick results.

Denial Risk

Testing Outside Covered Clinical Indications

Do not order urine culture testing for asymptomatic individuals unless an accepted indication applies. Testing for other asymptomatic situations does not meet criteria, including initial screening for asymptomatic prostatitis and assessment or prognosis of prostate biopsy.

Accepted asymptomatic indications include pregnancy and testing before urological intervention that breaches the mucosa.
Do not submit surveillance cultures or cultures for asymptomatic bacteriuria in individuals without an accepted indication.

Denial Risk

Inaccurate Documentation or Coding

Failure to follow documentation, coding, billing, or current reimbursement-policy requirements creates denial and recoupment risk. Ensure the claim accurately reflects the service performed and the documented indication.

Oscar may deny the claim and/or recoup payment when appropriate coding or billing guidelines or reimbursement policies are not followed.
Coverage criteria are applied subject to the member’s benefit coverage, applicable authorization requirements, medical necessity rules, contracts, mandates, and other governing policies.

Denial Risk

Asymptomatic Testing Without an Accepted Indication

Avoid low-value urine cultures in asymptomatic patients because positive or false-positive results can prompt unnecessary antibiotics, adverse drug events, resistant organisms, C. difficile infection, imaging, and delayed evaluation of the actual cause of a clinical change.

Do not screen or treat asymptomatic bacteriuria in individuals without risk factors, including well-regulated diabetes, post-menopausal status, elderly institutionalization, dysfunctional or reconstructed lower urinary tracts, renal transplant, recurrent UTI, or prior cardiovascular surgery unless another accepted indication applies.
Exceptions include pregnancy and planned urological procedures breaching the mucosa; recurrent UTI should be symptomatic, and culture is recommended for diagnosis.
Do not routinely culture asymptomatic catheterized patients or use cloudy or odorous urine, or pyuria alone, to diagnose catheter-associated UTI.

Billing Rule

Inappropriate Follow-Up or Specimen Collection

Do not order routine follow-up urine cultures after treatment when an uncomplicated UTI has clinically resolved. In febrile infants, avoid inappropriate collection practices and follow the age-, risk-, urinalysis-, and illness-based pathway before deciding whether culture is needed.

Clinical resolution is generally sufficient to assess effectiveness of antibiotic therapy for an uncomplicated UTI.
Do not use a urine bag culture to establish UTI in young children; use catheterization or suprapubic aspirate when culture is indicated, or a midstream specimen when the child is toilet-trained.
Obtain urine before antibiotics whenever possible; a negative urinalysis may support monitoring in an appropriate low-risk child but does not rule out UTI with certainty.

Urinary tract infections, including cystitis, may be symptomatic or asymptomatic.

Definition

DefinitionPyelonephritis is an infection of the upper urinary tract or kidney.

Culture useFor pyelonephritis, urine culture and antimicrobial susceptibility testing are recommended.

Clinical categoryPyelonephritis is a type of urinary tract infection.

Definition

DefinitionUTI means urinary tract infection.

Clinical presentationUrinary tract infections may be symptomatic or asymptomatic.

ExamplesUTIs can include cystitis, pyelonephritis, urosepsis, urethritis, bacterial prostatitis, and epididymitis.

Definition

AbbreviationASB means asymptomatic bacteriuria.

DefinitionASB is bacteriuria in the absence of symptoms localizing to the urinary tract.

General guidanceGuidelines generally recommend against screening for or treating ASB except in selected circumstances, such as pregnancy or before urologic procedures involving mucosal trauma.

Definition

DefinitionAn uncomplicated UTI is acute, sporadic, or recurrent cystitis limited to non-pregnant individuals.

Anatomical criteriaThere are no known relevant anatomical or functional abnormalities within the urinary tract.

Comorbidity criteriaThe individual has no relevant comorbidities.

Definition

DefinitionA complicated UTI is a UTI in a patient with an increased chance of a complicated course.

Population factorsComplicated UTI includes all men and pregnant individuals.

Clinical factorsAssociated factors include relevant urinary-tract abnormalities, indwelling urinary catheters, renal disease, and immunocompromising diseases, including diabetes.

Definition

DefinitionComplicated urinary tract infection (cUTI) occurs in an individual with factors that may worsen the clinical course or treatment success.

Examples of risk factorsExamples include diabetes, immunosuppression, and anatomical or functional urinary-tract abnormalities.

Additional associated factorsOther associated factors include vesicoureteral reflux, recent instrumentation, male sex, pregnancy, and healthcare-associated infection.

Definition and treatment context

DefinitionASB is bacteriuria without symptoms localizing to the urinary tract.

Usual guidanceMost cited guidelines recommend against screening or treating ASB in asymptomatic populations.

Selected exceptionsSelected exceptions include pregnancy and planned urologic procedures involving mucosal trauma.

Definition and diagnostic limitations

DefinitionCAUTI is a urinary infection occurring in a patient with a urinary catheter.

Cloudy or odorous urineThe presence or absence of cloudy or odorous urine alone should not distinguish catheter-associated ASB from CAUTI.

PyuriaPyuria should not be used as the sole indicator for catheter-associated UTI.

Kidney transplant context

DefinitionIn kidney transplant guidance, ASB is bacteriuria identified in a patient without relevant urinary symptoms.

Routine management after two monthsRoutine urine culture collection or treatment of bacteriuria is not recommended for asymptomatic kidney transplant patients more than two months after transplantation.

Confirmation before treatment decisionIf ASB is identified during screening, a second urine culture should be collected and reviewed before deciding whether to treat.

Additional asymptomatic UTI or asymptomatic bacteriuria testing is not covered when no accepted indication is present. Follow-up or surveillance cultures are also excluded after clinical resolution or when performed routinely in asymptomatic adults or kidney transplant recipients beyond 2 months after transplantation.

Urine culture testing is not covered when it is obtained solely for low-value screening, nonspecific findings, or routine surveillance in an asymptomatic patient. This includes reliance on pyuria, cloudy or odorous urine, routine catheter cultures, and cultures for asymptomatic adults without pregnancy or qualifying mucosa-traumatizing instrumentation.